Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, Vitamin D Nuclear Receptor | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
Vitamin D3 receptor | 0 | 0 | 1 | 1 |
USP1 protein, partial | 1 | 0 | 0 | 1 |
PPM1D protein | 1 | 0 | 0 | 1 |
Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 1 | 0 | 0 | 1 |
mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
geminin | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 | 1 | 0 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 3 | 0 | 3 |
Multidrug resistance-associated protein 4 | 0 | 3 | 0 | 3 |
Bile salt export pump | 0 | 3 | 0 | 3 |
Interferon beta | 2 | 0 | 0 | 2 |
Vitamin D-binding protein | 0 | 0 | 1 | 1 |
Cytochrome P450 1A2 | 0 | 0 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 3 | 0 | 4 |
Androgen receptor | 0 | 1 | 0 | 1 |
Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
Vitamin D3 receptor | 0 | 1 | 2 | 4 |
Cytochrome P450 2C9 | 0 | 2 | 0 | 3 |
Vitamin D3 receptor | 0 | 1 | 1 | 3 |
Retinoic acid receptor RXR-alpha | 0 | 0 | 1 | 1 |
Cytochrome P450 2C19 | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 0 | 1 | 1 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 1 | 1 | 2 |
Transporter | 0 | 1 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 3 | 0 | 3 |
Vitamin D3 receptor A | 0 | 0 | 2 | 2 |
RAR-related orphan receptor gamma | 1 | 0 | 0 | 1 |
retinoid X nuclear receptor alpha | 1 | 0 | 0 | 1 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 1 | 0 | 0 | 1 |
Sterol 14-alpha-demethylase | 0 | 0 | 1 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 1 | 0 | 0 | 1 |
EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
G | 1 | 0 | 0 | 1 |
14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Cholesterol side-chain cleavage enzyme, mitochondrial | 0 | 0 | 1 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
Cytochrome P450 144 | 0 | 0 | 1 | 1 |
Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Sterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
Cholesterol 24-hydroxylase | 0 | 2 | 1 | 3 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
polyprotein | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 1 | 0 | 0 | 1 |
Butyrophilin subfamily 3 member A1 | 0 | 0 | 1 | 2 |
Carbonic anhydrase 12 | 0 | 1 | 0 | 1 |
Geranylgeranyl pyrophosphate synthase | 0 | 2 | 0 | 3 |
Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
Farnesyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
Neutrophil collagenase | 0 | 1 | 0 | 1 |
Farnesyl diphosphate synthase | 0 | 1 | 0 | 1 |
Matrix metalloproteinase-14 | 0 | 1 | 0 | 1 |
Farnesyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
Geranylgeranyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 1 |
Farnesyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
H | 0 | 1 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |